Evidence map›Paper›PMID 31145428›Full record

ArticleAmerican journal of epidemiology2019

Utility of the 5-Minute Apgar Score as a Research Endpoint.

Marit L Bovbjerg, Mekhala V Dissanayake, Melissa Cheyney, Jennifer Brown, Jonathan M Snowden

Abstract read
In one paragraph

Article in American journal of epidemiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marit L BovbjergEpidemiology Program, College of Public Health and Human Sciences, Oregon State University, Corvallis, Oregon.
Mekhala V DissanayakeDepartment of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon.
Melissa CheyneyAnthropology Program, College of Liberal Arts, Oregon State University, Corvallis, Oregon.
Jennifer BrownDepartment of Epidemiology, School of Public Health, University of Washington, Seattle, Washington.
Jonathan M SnowdenSchool of Public Health, Oregon Health and Science University-Portland State University, Portland, Oregon.

Funding

Cesarean delivery in overweight and obese women: patient and systems factorsR00HD079658 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI SNOWDEN, JONATHAN M · 2016 to 2018
$725k
NICHD NIH HHS R00 HD079658
6 · The paper itself

Abstract

Although Apgar scores are commonly used as proxy outcomes, little evidence exists in support of the most common cutpoints (<7, <4). We used 2 data sets to explore this issue: one contained planned community births from across the United States (n = 52,877; 2012-2016), and the other contained hospital births from California (n = 428,877; 2010). We treated 5-minute Apgars as clinical "tests," compared against 18 known outcomes; we calculated sensitivity, specificity, positive and negative predictive values, and the area under the receiver operating characteristic curve for each. We used 3 different criteria to determine optimal cutpoints. Results were very consistent across data sets, outcomes, and all subgroups: The cutpoint that maximizes the trade-off between sensitivity and specificity is universally <9. However, extremely low positive predictive values for all outcomes at <9 indicate more misclassification than is acceptable for research. The areas under the receiver operating characteristic curves (which treat Apgars as quasicontinuous) were generally indicative of adequate discrimination between infants destined to experience poor outcomes and those not; comparing median Apgars between groups might be an analytical alternative to dichotomizing. Nonetheless, because Apgar scores are not clearly on any causal pathway of interest, we discourage researchers from using them unless the motivation for doing so is clear.

Indexed as

Apgar ScoreBiomedical ResearchArea Under CurveDatasets as TopicEpidemiologic MethodsHumansInfant, NewbornInfant, Newborn, DiseasesPredictive Value of TestsRisk FactorsROC CurveSensitivity and SpecificityApgar scoreinfant healthROC curve

Identifiers

PMID31145428
PMCPMC6736341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.